Trial intelligence / Profile preview

Allya (Devil's Claw) in Knee and Hip Osteoarthritis

NCT00295490Phase 2Terminated

Sponsor
University of Southampton
Start
Dec 2004
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Allya in osteoarthritis (OA), sponsored by University of Southampton. Started Dec 2004; status: terminated.

02

Drugs

Allya
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00295490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00295490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call